These results indicated that various tumor progression- and immune activation-associated pathways, particularly extracellular matrix organization, cytokine signaling in the immune system and interferon alpha/beta signaling, activated inflammation and reflecting relatively enhanced tumor progression, were enriched in the high SLC11A1 subgroup (Supplementary Figure 2D). The gene discussed is SLC11A1; the disease is neoplasm.